SCA
PIII icon

Salient Capital Advisors’s P3 Health Partners PIII Stock Holding History

Salient Capital Advisors’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$197K – 81
2021
Q3 		$197K Buy
+400
New +$197K 0.01% 51

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return

Salient Capital Advisors's PIII Position: Q4 2021 in Review

Salient Capital Advisors sold out of P3 Health Partners (PIII) in Q4 2021, closing a stake of 400 shares — an estimated $197K sold.

Salient Capital Advisors first reported a position in PIII in Q3 2021 and held it in 1 quarter. The position peaked at $197K in Q3 2021. 24 funds tracked by Wall St. Rank hold PIII as of Q4 2021.

  • Salient Capital Advisors reported no remaining P3 Health Partners position as of Q4 2021 after selling out during the quarter.
  • Salient Capital Advisors sold 400 P3 Health Partners shares in Q4 2021, an estimated $197K.
  • Salient Capital Advisors first reported a position in P3 Health Partners in Q3 2021 and held it in 1 quarter.
  • Salient Capital Advisors's P3 Health Partners position peaked at $197K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2021.

Based on Salient Capital Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.